Phase 2 clinical trial of neutralising antibody cocktail in SARS-CoV-2 treatment
Latest Information Update: 02 Oct 2020
At a glance
- Drugs Neutralising antibody cocktail-Lumen Bioscience (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Sponsors Lumen Bioscience
- 02 Oct 2020 New trial record
- 24 Sep 2020 According to a Lumen Bioscience media release, By spring 2021 the program aims to initiate Phase 2 clinical trials